Interactive Labs · Human Biology Simulator
Follow a dose from the gut to the blood, and see where it is lost.
Simulated and hypothetical. The lab describes no real ingredient, product or person and is not a dose recommendation. Equations and limits
Simulator
Simulated plasma concentration, mg/L Simulated
- Parameters as set
- Median of 200 simulated people
- 5th to 95th percentile
- Dose times
Where the doses given so far are, as a share of everything given Simulated
Compartments at the chosen time Simulated
Show the concentration curve as a table
| Time, h | As set, mg/L | Median, mg/L | 5th–95th percentile, mg/L |
|---|
One mechanism at a time
Each scenario sets hypothetical parameters chosen to show a single mechanism. This lab makes no individual predictions: it has no inputs for body weight, age, sex, genes, health or other medicines, and it must not be used to choose a dose.
- Most of the dose never crosses the gut wall (low Fa), so it leaves unabsorbed.
- A large liver intrinsic clearance removes most of what arrives from the gut before it reaches the blood.
- When absorption is slower than elimination, the slow absorption sets how fast the level falls (“flip-flop”).
- A large tissue volume pulls the compound out of the blood and releases it slowly.
- Doses given faster than the body clears them build up until intake and elimination balance.
Equations, assumptions and limits
Fh = QH / (QH + fu·CLint), CLH = QH·fu·CLint / (QH + fu·CLint), QH = 99.5 L/h
dA1/dt = Fg·Fh·kaAg − (CLH + CLR)·A1/V1 − Q·A1/V1 + Q·A2/V2
dA2/dt = Q·A1/V1 − Q·A2/V2; C = A1/V1; F = Fa·Fg·Fh
- Model
- Two well-mixed body compartments (blood and rapidly equilibrating tissue, and slower tissue) with first-order absorption from the gut. Absorbed compound passes the gut wall, where a fraction 1 − Fg is metabolized, then the liver, where the well-stirred model sets the first-pass loss 1 − Fh and the same liver keeps clearing what circulates (CLH). The kidney clears CLR.
- Numerics
- Fourth-order Runge–Kutta, step 0.01 h (0.02 h for the 200 simulated people). Every milligram is tracked: unabsorbed, in the gut, metabolized in the gut wall, removed on the first pass, in the body, removed by the liver afterwards and excreted by the kidney. The page reports how closely these add up to the doses given.
- Variability
- Each simulated person draws CLint, V1 and ka as θ·eη with η normal, variance ln(1 + CV²), the exponential form commonly used for between-subject variability in population pharmacokinetics. The CV is yours to set, and the band shows only what that assumption implies.
- Assumptions
- Linear kinetics and a blood-to-plasma ratio of 1. No lag time, enterohepatic recycling, transporter or enzyme saturation, or metabolites. The liver blood flow QH is the reference adult male value.
- Limits
- Many botanical constituents are extensively metabolized, so what circulates is mostly metabolites, which this model ignores. The same blood level can come from very different parameter combinations. A higher blood level does not by itself mean a larger benefit or a safe intake.
- Sources
- Pang KS, Rowland M. J Pharmacokinet Biopharm 1977;5:625–653 (well-stirred liver model). ICRP Publication 89 (2002), Tables 2.39 and 2.40 (reference liver blood flow, 99.5 L/h, as used on ADME and pharmacokinetics). Varma MVS, et al. J Med Chem 2010;53:1098–1108 (F = Fa·Fg·Fh). Mould DR, Upton RN. CPT Pharmacometrics Syst Pharmacol 2013;2:e38 (compartment models; between-subject variability). Grogan S, Preuss CV. Pharmacokinetics, StatPearls 2023 (half-life, clearance, accumulation).
Health information notice
These statements have not been evaluated by the Food and Drug Administration. Nothing on this site is intended to diagnose, treat, cure or prevent any disease. The information is for general education only. It is not medical advice and does not replace advice, diagnosis or treatment from a qualified health professional, or any medication a clinician has prescribed.
Do not start, stop or change any medicine, supplement or herbal product because of something you read here. Talk to your doctor or pharmacist first, especially if you are pregnant or breastfeeding, have a medical condition, take any medicines, are preparing for surgery, or are caring for a child. Research findings, traditional uses and safety data are reported as their sources state them; they are not recommendations or claims about any product. If you think you may have a medical emergency, call your doctor or 911 at once.
EUTECNIQ Sciences sells no supplements or health products today and receives nothing from any product or ingredient mentioned on this site; any commercial interest it later has in an ingredient will be stated on that ingredient’s page.